This article is more than 5 years old. Information may no longer be current.
Global panel issues consensus on role of IOP in glaucoma
Click Here to Manage Email Alerts
SINGAPORE — A panel of experts working under the auspices of the World Glaucoma Association has reached a consensus on the role of IOP in glaucoma. The consensus recognizes IOP as the primary risk factor for glaucoma progression and that lowering IOP is the only approach proven to slow or prevent such progression, the association announced in a press release.
The World Glaucoma Association convened the panel, which represents 70 of the world's principal glaucoma societies, in an effort to more clearly define the relationship between IOP and the optic nerve. The panel announced its consensus statement at the World Glaucoma Congress here.
The panel considered seven consensus points, which included determinants of IOP, measurement of IOP and clinical IOP targets. In particular, the panel emphasized the importance of evaluating IOP on an individual basis, depending on the progression of the disease. It also underscored the important influence of central corneal thickness on IOP measurements, according to the release.
"It is vital to define clearly how IOP relates to optic nerve damage to improve patient care and to achieve consistency in glaucoma management across the globe," Robert N. Weinreb, MD, the chairman of the consensus committee, said in the release.
This is the fourth consecutive annual consensus statement released by the group, the release said.